# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Toast, Teva, Vistra, Equinix, Applovin, IFF, Constellation, Emerson, IP, and STERIS were top performers last week. Are they in ...
Mizuho analyst Dan Dolev maintains Toast (NYSE:TOST) with a Neutral and raises the price target from $17 to $21.
Piper Sandler analyst Clarke Jeffries maintains Toast (NYSE:TOST) with a Neutral and raises the price target from $20 to $25.
Toast witnessed a remarkable surge of nearly 14% in its share price Wednesday following the release of its first-quarter 2024 f...
RBC Capital analyst Daniel Perlin maintains Toast (NYSE:TOST) with a Sector Perform and raises the price target from $23 to ...
Canaccord Genuity analyst David Hynes maintains Toast (NYSE:TOST) with a Buy and raises the price target from $22 to $28.